News | Radiation Therapy | February 08, 2016

ASRT Foundation Reaches $2.5 Million Dollar in 30-Year Anniversary Campaign

Funds raised from Positioning for a Brighter Tomorrow campaign will go toward education and training, collaborative efforts with other organizations

February 8, 2016 — The ASRT Foundation’s 30th anniversary celebration campaign reached a major milestone in January with more than $2.5 million raised in commitments from individuals and organizations. The funds donated for this campaign will be used to ensure medical imaging and radiation therapy professionals attain the level of education, leadership and influence required to meet the needs of patients for many years to come.

Launched in June 2014, the Positioning for a Brighter Tomorrow campaign provides the foundation​ — the philanthropic arm of the American Society of Radiologic Technologists — with long-term financial stability in its efforts to empower radiologic technologists and strengthen the radiologic technology profession. In addition, the campaign works to improve collaboration with industry partners to increase the quality and safety of patient care around the world for years to come. The campaign will continue through June 2016.

The Foundation invites individuals and corporations to make transformational gifts that will help medical imaging and radiation therapy professionals and students advance through scholarships, research grants and community outreach programs. In addition, donations will enhance collaborative initiatives to improve radiologic technologist education and patient care.

As part of the campaign, the Foundation is offering individuals and corporations the opportunity to have their names included on the ASRT Foundation Donor Wall, which is adjacent to the ASRT Museum and Archives at ASRT's national office in Albuquerque, N.M. In addition, campaign supporters have the option to purchase naming rights to facilities and meeting spaces at the ASRT office, and to create new, personalized program awards with their gift to the campaign.

Those wishing to participate may donate cash, leave a deferred gift through a will or trust, provide a combined gift or make a contribution with stock, mutual funds or marketable securities.

For more information:

Related Content

RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Clinical Trials and Cutting-Edge Radiation Oncology Research to Be Featured at ASTRO 2017
News | Radiation Therapy | September 14, 2017
The program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San...
Provision Healthcare Joins RayCare Clinical Partners
News | Oncology Information Management Systems (OIMS) | September 11, 2017
Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its...
U.K.'s NICE Supports Use of Hydrogel Spacer in Prostate Cancer Treatement
News | Patient Positioning Radiation Therapy | September 08, 2017
Augmenix Inc. announced that the National Institute for Health and Care Excellence (NICE) in the U.K. has issued...
Sponsored Content | Videos | Radiation Therapy | September 08, 2017
The new Visicoil MR is a helically-wound, flexible linear fiducial marker.
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Overlay Init